⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23129909 | 0.88 | MTNR1A (0.31) | — | |
| SCHEMBL19663688 | 0.88 | — | — | |
| SCHEMBL18797981 | 0.85 | MTNR1A (0.32) | — | |
| SCHEMBL19662835 | 0.85 | MTNR1A (0.31) | — | |
| SCHEMBL18797964 | 0.83 | MEN1 (0.32) | — | |
| SCHEMBL18797979 | 0.83 | MTNR1A (0.35) | — | |
| SCHEMBL21539671 | 0.83 | — | — | |
| SCHEMBL18797989 | 0.83 | MTNR1A (0.32) | — | |
| SCHEMBL18797978 | 0.82 | MTNR1A (0.34) | — | |
| SCHEMBL17337191 | 0.81 | TSHR (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3154989-B1 | BETA-LACTAMASE INHIBITORS | VENATORX PHARMACEUTICALS INC (US) | 2021-03-24 | — | — | EP | disclosed |
| US-9926336-B2 | Beta-lactamase inhibitors | VENATORX PHARMACEUTICALS (US) | 2018-03-27 | — | — | US | disclosed |
| US-20170342092-A1 | BETA-LACTAMASE INHIBITORS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2017-11-30 | — | — | US | disclosed |